Search by Drug Name or NDC

    NDC 36800-0502-05 COLD AND FLU SEVERE 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1 Details

    COLD AND FLU SEVERE 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1

    COLD AND FLU SEVERE is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by TOPCARE. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 36800-0502
    Product ID 36800-502_d0d6b2c5-5332-e798-e053-2a95a90a381a
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name COLD AND FLU SEVERE
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 325; 10; 200; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name TOPCARE
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 36800-0502-05 (36800050205)

    NDC Package Code 36800-502-05
    Billing NDC 36800050205
    Package 2 BLISTER PACK in 1 CARTON (36800-502-05) / 12 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2013-07-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL cbb179c8-31fb-4a3a-9f23-4024350f8b7f Details

    Revised: 11/2021